PLSE 424B5: Secondary offering
Pulse Biosciences
Filed with the SEC on · accession 0001437749-26-030455
PLSE filed a 424B5 (prospectus (offering)) with the SEC on Sep 15, 2026. The final terms of an offering of shares or bonds. The stock moved +1.8% by the first close after the filing.
Summary of the filing
Pulse Biosciences entered into a sales agreement with Mizuho Securities to sell up to $85 million of common stock in an at-the-market offering, supplementing a prior August 2026 agreement under which $68.8 million had already been sold.
Key details
How PLSE stock reacted
Close before
$54.21
Sep 14, 2026
First close after
+1.83%
$55.20
5 trading days
-1.66%
$53.31
Since filing
-2.10%
$53.07
✦ Ask GOAX AI about this filing — what it means for PLSE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PLSE?
Click hereFrequently asked questions
What did PLSE file with the SEC on Sep 15, 2026?
PLSE filed a 424B5 (Secondary offering). Pulse Biosciences entered into a sales agreement with Mizuho Securities to sell up to $85 million of common stock in an at-the-market offering, supplementing a prior August 2026 agreement under which $68.8 million had already been sold.
What does a secondary offering mean for PLSE stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did PLSE stock react to this filing?
PLSE closed at $54.21 before the filing and $55.20 on Sep 15, 2026 (+1.83%). Five trading days later: $53.31 (-1.66%).
Other PLSE SEC filings
- 8-K · SEC filingNov 6, 2026
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · Contract winOct 14, 2026
- 8-K · Fda approvalOct 7, 2026
- 8-K · Fda approvalSep 15, 2026
- 8-K · Secondary offeringSep 15, 2026
- 10-Q · SEC filingAug 6, 2026
- 424B5 · Secondary offeringAug 6, 2026
- 8-K · Guidance raiseAug 6, 2026
Get alerts when PLSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days